The influence of tumor necrosis factor-α on the tumorigenic Wnt-signaling pathway in human mammary tissue from obese women

Oncotarget. 2017 May 30;8(22):36127-36136. doi: 10.18632/oncotarget.16632.

Abstract

Epidemiological studies have convincingly suggested that obesity is an important risk factor for postmenopausal breast cancer, but the mechanisms responsible for this relationship are still not fully understood. We hypothesize that obesity creates a low-grade inflammatory microenvironment, which stimulates Wnt-signaling and thereby promotes the development of breast cancer. To test this hypothesis, we evaluated the correlations between expression of multiple inflammatory cytokines and Wnt pathway downstream genes in mammary tissues from women (age ≥ 50) undergoing reduction mammoplasty. Moreover, we specifically examined the role of tumor necrosis factor-α (TNF-α), an important proinflammatory cytokine associated with obesity and a possible modulator of the Wnt pathway. The regulatory effects of TNF-α on Wnt pathway targets were measured in an ex vivo culture of breast tissue treated with anti-TNF-α antibody or TNF-α recombinant protein. We found that BMI was positively associated with the secretion of inflammatory cytokines IL-1β, IL-6 and TNF-α, all of which were negatively correlated with the expression of SFRP1. The transcriptional expression of Wnt-signaling targets, AXIN2 and CYCLIN D1, were higher in mammary tissue from women with BMI ≥ 30 compared to those with BMI < 30. Our ex vivo work confirmed that TNF-α is causally linked to the up-regulation of active β-CATENIN, a key component in the Wnt pathway, and several Wnt-signaling target genes (i.e. CYCLIN D1, AXIN2, P53 and COX-2). Collectively, these findings indicate that obesity-driven inflammation elevates Wnt-signaling in mammary tissue and thereby creates a microenvironment conducive to the development of breast cancer.

Keywords: Wnt pathway; breast cancer; inflammation; obesity; tumor necrosis factor-α.

MeSH terms

  • Antibodies, Blocking / pharmacology
  • Axin Protein / genetics
  • Axin Protein / metabolism
  • Breast Neoplasms / complications
  • Breast Neoplasms / immunology*
  • Cell Proliferation
  • Cells, Cultured
  • Cyclin D1 / genetics
  • Cyclin D1 / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Inflammation / immunology*
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Mammary Glands, Human / physiology*
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Middle Aged
  • Obesity / complications
  • Obesity / immunology*
  • Tumor Microenvironment
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism*
  • Wnt Signaling Pathway
  • beta Catenin / metabolism

Substances

  • AXIN2 protein, human
  • Antibodies, Blocking
  • Axin Protein
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1beta
  • Interleukin-6
  • Membrane Proteins
  • SFRP1 protein, human
  • Tumor Necrosis Factor-alpha
  • beta Catenin
  • Cyclin D1